Detalhe da pesquisa
1.
Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial.
Blood
; 136(26): 3041-3050, 2020 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367545
2.
Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group.
Blood
; 134(19): 1608-1618, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31554635
3.
Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1-mutated acute myeloid leukemia receiving gemtuzumab ozogamicin.
Haematologica
; 106(11): 2986-2989, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34047179
4.
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease.
J Hematol Oncol
; 16(1): 96, 2023 08 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37587502
5.
Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial.
Lancet Haematol
; 10(7): e495-e509, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37187198
6.
Pharmacotherapeutic management of T-cell acute lymphoblastic leukemia in adults: an update of the literature.
Expert Opin Pharmacother
; 23(5): 561-571, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35193450
7.
18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting.
Pathogens
; 11(3)2022 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35335672
8.
Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study.
J Clin Oncol
; 38(6): 623-632, 2020 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31851556
9.
Clonal evolution patterns in acute myeloid leukemia with NPM1 mutation.
Nat Commun
; 10(1): 2031, 2019 05 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048683
10.
TP53 abnormalities and chromosomal aneuploidy in acute panmyelosis with myelofibrosis.
Leukemia
; 33(12): 2956-2962, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350530